Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for human PD1 gene specific knockout through CRISPR-Cas9 (clustered regularly interspaced short palindromic repeat) and sgRNA(single guide RNA)for specially targeting PD1 gene

A pgl3-u6-hpd1sg, specific technology, applied in the field of genetic engineering, can solve problems such as laborious, time-consuming and expensive antibody drugs

Active Publication Date: 2014-05-28
AOMIAO BIOTECH GUANGZHOU CO LTD
View PDF1 Cites 117 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] Aiming at the existing problems in the use of PD1 antibody for immune detection and blocking treatment of tumors: (1) The effect of the antibody is only a temporary blocking effect; (2) There are many kinds of inhibitory receptors, how to use multiple antibodies to block various There is no countermeasure for inhibitory receptors; (3) It is not easy to develop effective antibodies; (4) It only targets extracellular targets; (5) The development of antibody drugs is time-consuming, laborious, and expensive, making antibody drugs expensive, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for human PD1 gene specific knockout through CRISPR-Cas9 (clustered regularly interspaced short palindromic repeat) and sgRNA(single guide RNA)for specially targeting PD1 gene
  • Method for human PD1 gene specific knockout through CRISPR-Cas9 (clustered regularly interspaced short palindromic repeat) and sgRNA(single guide RNA)for specially targeting PD1 gene
  • Method for human PD1 gene specific knockout through CRISPR-Cas9 (clustered regularly interspaced short palindromic repeat) and sgRNA(single guide RNA)for specially targeting PD1 gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Example 1 Design and synthesis of sgRNA for specifically targeting PD1 gene in CRISPR-Cas9 specific knockout of human PD1 gene

[0061] 1. Design of sgRNA targeting human PD1 gene:

[0062] (1) Select the 5'-GGN(19)GG sequence on the PD1 gene. If there is no 5'-GGN(19)GG sequence, 5'-GN(20)GG or 5'-N(21)GG is also Can.

[0063] (2) The target site of sgRNA on the PD1 gene is located in the exon of the gene, which is more likely to cause the deletion of the fragment or the frame-shift mutation, so as to achieve the purpose of complete gene inactivation.

[0064] (3) The targeting site of sgRNA on the PD1 gene is located on the common exons of different splicing forms.

[0065] (4) Use BLAT in the UCSC database or BLAST in the NCBI database to determine whether the target sequence of the sgRNA is unique and reduce potential off-target sites.

[0066] According to the above method, we designed a total of 180 sgRNAs targeting the human PD1 gene, the sequences of which ar...

Embodiment 2

[0087] Example 2 Using CRISPR-Cas9 to specifically knock out the human PD1 gene (the sgRNA used to target the PD1 gene is shown in Sequence Table 52)

[0088] 1. The linearized sequence is the pGL3-U6-sgRNA plasmid shown in the sequence table SEQ ID NO.10.

[0089] Enzyme digestion system and conditions are as follows:

[0090] 2 μg pGL3-U6-sgRNA (400ng / μl);

[0091] 1μl CutSmart Buffer;

[0092] 1 μl BsaI (NEB, R0535L);

[0093] Replenish water to 50 μl, incubate at 37°C for 3-4 hours, shake and centrifuge at regular intervals to prevent droplets from evaporating onto the tube cap.

[0094] After digestion, use AxyPrep PCR Clean up Kit (AP-PCR-250) to purify and recover to 20-40 μl sterilized water.

[0095] 2. Combine the double-stranded sgRNA oligonucleotides obtained after denaturation and annealing that can be connected to the U6 eukaryotic expression vector (the sequences of their Forward oligo and Reverse oligo are shown in the sequence table SEQ ID NO.1 and 2, resp...

Embodiment 3

[0125] Example 3 Using CRISPR-Cas9 to specifically knock out the human PD1 gene (the sgRNA used to target the PD1 gene is shown in the sequence table as SEQ ID NO.82)

[0126] 1. The linearized sequence is the pGL3-U6-sgRNA plasmid shown in the sequence table SEQ ID NO.10.

[0127] Enzyme digestion system and conditions are as follows:

[0128] 2 μg pGL3-U6-sgRNA (400ng / μl);

[0129] 1μl CutSmart Buffer;

[0130] 1 μl BsaI (NEB, R0535L);

[0131] Replenish water to 50 μl, incubate at 37°C for 3-4 hours, shake and centrifuge at regular intervals to prevent droplets from evaporating onto the tube cap.

[0132] After digestion, use AxyPrep PCR Clean up Kit (AP-PCR-250) to purify and recover to 20-40 μl sterilized water.

[0133] 2. The double-stranded sgRNA oligonucleotides obtained after denaturation and annealing that can be connected to the U6 eukaryotic expression vector (the sequences of their Forward oligo and Reverse oligo are shown in the sequence table SEQ ID NO.3 an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of genetic engineering, particularly relates to a method for human PD1 gene specific knockout through CRISPR-Cas9 (clustered regularly interspaced short palindromic repeat) and sgRNA(single guide RNA)for specially targeting a PD1 gene, and provides a method for human PD1 gene specific knockout through CRISPR-Cas9 and sgRNA(single guide RNA) for specially targeting a PD1 gene. The sgRNA(single guide RNA)for specially targeting a human PD1 gene, prepared through adopting the method provided by the invention, can be used for accurately targeting the human PD1 gene and realizes gene knockout; the preparing method has simple steps, the targeting performance of the sgRNA is good, and the knockout efficiency of a CRISPR-Cas9 system is high.

Description

technical field [0001] The invention belongs to the field of genetic engineering, and more specifically relates to a CRISPR-Cas9 method for specifically knocking out the human PD1 gene and an sgRNA for specifically targeting the PD1 gene. Background technique [0002] The clustered regularly interspaced short palindromic repeat system (clustered regularly interspaced short palindromic repeat; CRISPR-associated, CRISPR-Cas9) is a complex with endonuclease activity that recognizes a specific DNA sequence and cuts it at a specific site. Double-strand breaks (Double-strand breaks, DSB), in the absence of template conditions, non-homologous end joining (Non-homologous end joining, NHEJ), resulting in frameshift mutation (frameshift mutation), resulting in gene knockout ( figure 1 ). [0003] This technology has attracted widespread attention because it can quickly, easily and efficiently target any gene in the genome, and it became popular like an explosion in 2012. Cas9 has b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/113C12N15/85
Inventor 胡边黄行许
Owner AOMIAO BIOTECH GUANGZHOU CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com